This sums up my thoughts and fears as well. The only people talking about the stock are shareholders. How can not even one media outlet be reporting on the potential? I remember seeing articles of researchers at Oxford working with AstraZeneca. Not Oxford, but Texas A&M is a major university and not a whisper. Does this all go back to pathetic PR? Tweets from the doc are worthless.
As for R/S, the stock will have to increase 40x without one. Not likely. Just being realistic.
Still long but the management team needs to do better on the business side.
News 
Market Data 
Discover 
